Cargando…
SU6668 modulates prostate cancer progression by downregulating MTDH/AKT signaling pathway
Prostate cancer is the second leading cause of cancer deaths among men in Western counties and has increased in incidence also in China in recent years. Although diagnosis modalities for primary prostate cancer have markedly improved, there are still no effective therapies for metastatic prostate ca...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
D.A. Spandidos
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5403372/ https://www.ncbi.nlm.nih.gov/pubmed/28339027 http://dx.doi.org/10.3892/ijo.2017.3926 |